Circulating microparticles are elevated in carriers of Factor v Leiden

Thrombosis Research

Volumn 126, Issue 3, 2010, Pages 250-253

  Enjeti, Anoop K ^a,c,d   Lincz, Lisa F ^a,b,d   Scorgie, Fiona E ^a,d   Seldon, Michael ^a,c,d  

^a CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c HUNTER NEW ENGLAND HEALTH   (Australia)

^d HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

DVT; Factor V Leiden; Heterozygotes; Microparticles; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5 LEIDEN; CD45 ANTIGEN; FIBRINOGEN RECEPTOR; VENOM;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE; MALE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; SNAKE; THROMBOCYTE; THROMBOSIS;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ANTIGENS, CD45; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD PLATELETS; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; E-SELECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR V; FEMALE; FLOW CYTOMETRY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; MUTATION; NEW SOUTH WALES; PHENOTYPE; PLATELET MEMBRANE GLYCOPROTEIN IIB; PROTHROMBIN TIME; THROMBOSIS; UP-REGULATION;

EID: 77956265778     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.11.019     Document Type: Article

References (40)

1. W.W. Coon Venous thromboembolism. Prevalence, risk factors, and prevention Clin Chest Med 5 1984 391 401
2. A.T. Cohen, V.F. Tapson, J.F. Bergmann, S.Z. Goldhaber, A.K. Kakkar, and B. Deslandes Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study Lancet 371 2008 387 394
3. B. Dahlback Advances in understanding pathogenic mechanisms of thrombophilic disorders Blood 112 2008 19 27
4. T. Lammers Schambeck CM: Screening for thrombophilia. Hamostaseologie 28 2008 135 140
5. B. Dahlback The discovery of activated protein C resistance J Thromb Haemost 1 2003 3 9
6. P. Simioni, B.J. Sanson, P. Prandoni, D. Tormene, P.W. Friederich, and B. Girolami Incidence of venous thromboembolism in families with inherited thrombophilia Thromb Haemost 81 1999 198 202
7. K. Juul, A. Tybjaerg-Hansen, P. Schnohr, and B.G. Nordestgaard Factor V Leiden and the risk for venous thromboembolism in the adult Danish population Ann Intern Med 140 2004 330 337
8. R. Lensen, F. Rosendaal, J. Vandenbroucke, and R. Bertina Factor V Leiden: the venous thrombotic risk in thrombophilic families Br J Haematol 110 2000 939 945
9. F.R. Rosendaal, T. Koster, J.P. Vandenbroucke, and P.H. Reitsma High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood 85 1995 1504 1508
10. F.R. Rosendaal Risk factors for venous thrombotic disease Thromb Haemost 82 1999 610 619
11. V. De Stefano, P. Chiusolo, K. Paciaroni, and G. Leone Epidemiology of factor V Leiden: clinical implications Semin Thromb Hemost 24 1998 367 379
12. L.F. Lincz, A. Lonergan, F.E. Scorgie, P. Rowlings, R. Gibson, and A. Lawrie Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden Pathophysiol Haemost Thromb 35 2006 435 439
13. G. Tans, A. van Hylckama Vlieg, M.C. Thomassen, J. Curvers, R.M. Bertina, and J. Rosing Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women Br J Haematol 122 2003 465 470
14. N. Hezard, L. Bouaziz-Borgi, M.G. Remy, and P. Nguyen Utility of thrombin-generation assay in the screening of factor V G1691A (Leiden) and prothrombin G20210A mutations and protein S deficiency Clin Chem 52 2006 665 670
15. J.M. Freyssinet Cellular microparticles: what are they bad or good for? J Thromb Haemost 1 2003 1655 1662
16. Y.S. Ahn Cell-derived microparticles: 'Miniature envoys with many faces' J Thromb Haemost 3 2005 884 887
17. P.J.B.M. Newman, J. Griffin, I.J. Vague, and K.T. Preissner Minutes of working Group in Vascular biology accessed March http://wwwmeduncedu/isth/ssc 2005 2009
18. B. Furie, and B.C. Furie Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation Trends Mol Med 10 2004 171 178
19. D.D. Myers, A.E. Hawley, D.M. Farris, S.K. Wrobleski, P. Thanaporn, and R.G. Schaub P-selectin and leukocyte microparticles are associated with venous thrombogenesis J Vasc Surg 38 2003 1075 1089
20. O. Morel, F. Toti, B. Hugel, B. Bakouboula, L. Camoin-Jau, and F. Dignat-George Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 26 2006 2594 2604
21. T. Geiser, M. Sturzenegger, U. Genewein, A. Haeberli, and J.H. Beer Mechanisms of cerebrovascular events as assessed by procoagulant activity, cerebral microemboli, and platelet microparticles in patients with prosthetic heart valves Stroke 29 1998 1770 1777
22. M.B. Taubman, P.L. Giesen, A.D. Schecter, and Y. Nemerson Regulation of the procoagulant response to arterial injury Thromb Haemost 82 1999 801 805
23. E. Biro, K.N. Sturk-Maquelin, G.M. Vogel, D.G. Meuleman, M.J. Smit, and C.E. Hack Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner J Thromb Haemost 1 2003 2561 2568
24. R.B. Arteaga, J.A. Chirinos, A.O. Soriano, W. Jy, L. Horstman, and J.J. Jimenez Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome Am J Cardiol 98 2006 70 74
25. J.J. Jimenez, W. Jy, L.M. Mauro, L.L. Horstman, C. Soderland, and Y.S. Ahn Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation Br J Haematol 123 2003 896 902
26. I.A. Greer Endothelial cell microparticles and antiphospholipid syndrome: pathologic explanations and diagnostic opportunities Thromb Haemost 91 2004 636 638
27. V. Faure, L. Dou, F. Sabatier, C. Cerini, J. Sampol, and Y. Berland et al : Elevation of circulating endothelial microparticles in patients with chronic renal failure J Thromb Haemost 4 2006 566 573
28. K.T. Tan, and G.Y. Lip The potential role of platelet microparticles in atherosclerosis Thromb Haemost 94 2005 488 492
29. K.T. Tan, M.H. Tayebjee, C. Lynd, A.D. Blann, and G.Y. Lip Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers Ann Med 37 2005 61 66
30. L.L. Horstman, W. Jy, J.J. Jimenez, and Y.S. Ahn Endothelial microparticles as markers of endothelial dysfunction Front Biosci 9 2004 1118 1135
31. V.H. Gonzalez-Quintero, J.J. Jimenez, W. Jy, L.M. Mauro, L. Hortman, and M.J. O'Sullivan Elevated plasma endothelial microparticles in preeclampsia Am J Obstet Gynecol 189 2003 589 593
32. A.K. Enjeti, L.F. Lincz, and M. Seldon Detection and measurement of microparticles: an evolving research tool for vascular biology Semin Thromb Hemost 33 2007 771 779
33. R.M. Camire, M. Kalafatis, P. Simioni, A. Girolami, and P.B. Tracy Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C Blood 91 1998 2818 2829
34. M. Perez-Casal, C. Downey, K. Fukudome, G. Marx, and C.H. Toh Activated protein C induces the release of microparticle-associated endothelial protein C receptor Blood 105 2005 1515 1522
35. A.K. Enjeti, L. Lincz, and M. Seldon BioMaleimide as a Generic Stain for Detection and Quantitation of Microparticles Int J Lab Hematol 30 3 2008 Jun 196 199
36. V. Combes, A.C. Simon, G.E. Grau, D. Arnoux, L. Camoin, and F. Sabatier In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant J Clin Invest 104 1999 93 102
37. T. Exner, J. Joseph, J. Low, D. Connor, and D. Ma A new activated factor X-based clotting method with improved specificity for procoagulant phospholipid Blood Coagul Fibrinolysis 14 2003 773 779
38. B. Toth Microparticles and female issues Hamostaseologie 29 2009 46 50
39. O.P. Barry, D. Pratico, R.C. Savani, and G.A. FitzGerald Modulation of monocyte-endothelial cell interactions by platelet microparticles J Clin Invest 102 1998 136 144
40. D. Lechner, and A. Weltermann Circulating tissue factor-exposing microparticles Thromb Res 122 Suppl 1 2008 S47 54